All Stories

  1. The Italian biliary atresia registry: Insights and lessons from the retrospective analysis of a 10‐year period cohort
  2. Featured Cover
  3. Monosegment and Modified‐Monosegment, Reduced‐ and Hyperreduced‐ Left Lateral Segment Liver Transplantation in Children: The Way Forward to Improve the Outcome and the Transplant Offer for the Small Infants
  4. TDM-guided meropenem/vaborbactam-based therapy for successful treatment of intra-abdominal and bloodstream infection caused by KPC-producing ceftazidime/avibactam-resistant Klebsiella pneumoniae in a paediatric liver transplant recipient
  5. Brain Functional Connectivity Significantly Improves After Surgical Eradication of Porto-Systemic Shunting in Pediatric Patients
  6. Tailoring allocation policies and improving access to pediatric liver transplantation in Italy: Outframing and concluding
  7. Outcome of in situ split liver transplantation in Italy over the last 25 years: An alternative analysis and personal view
  8. Small‐for‐size liver graft syndrome. Not everything is what it seems to be: Even salt looks like sugar
  9. Featured Cover
  10. European Society of Pediatric Radiology survey of perioperative imaging in pediatric liver transplantation: (3) postoperative imaging
  11. Combining living and deceased donation for pediatric first isolated liver transplantation: A win‐win even in countries with high deceased donor donation rates
  12. Revisiting the forgotten “full‐right full‐left” liver division: Simplified technique and new strategical considerations for clinical implementation in Italy
  13. Statistical Approaches to Identify Pairwise and High-Order Brain Functional Connectivity Signatures on a Single-Subject Basis
  14. Portal vein reconstruction at transplanting biliary atresia infants: A rabbit and tortoise story
  15. Pediatric Liver and Transplant Surgery: Results of an International Survey and Expert Consensus Recommendations
  16. Variability of Care and Access to Transplantation for Children with Biliary Atresia Who Need a Liver Replacement
  17. Letter to the editor: Liver splitting during ex situ perfusion: Do not count your chickens before they are hatched…
  18. Letter to the editor: Organ shortage and pediatric liver transplantation: David against Goliath…
  19. European Liver Transplant Registry: Donor and transplant surgery aspects of 16,641 liver transplantations in children
  20. Anatomy of reducing left liver lobe grafts and monosegmental liver transplantation: Tell it as it is
  21. Bile duct anatomical variations: Relevance for liver division and preparing left split liver grafts for pediatric transplantation: Cohort study
  22. Optimizing Liver Division Technique for Procuring Left Lateral Segment Grafts: New Anatomical Insights
  23. Domino-liver transplantation: toward a safer and simpler technique in both donor and recipient
  24. Unusual Clinical Course for Untreated Malformative Biliary Atresia Infant
  25. Preliminary Analysis of the Impact of the Coronavirus Disease 2019 Outbreak on Italian Liver Transplant Programs
  26. Novel Arterial Reconstruction With Donor Femoral Artery in Split‐Liver Transplantation
  27. Liver Transplantation for Pediatric Liver Cancer
  28. A Right and a Left … With a Simple Needle…
  29. Case report: horse or zebra, ascites or pseudo-ascites? Care for pictural details!
  30. Cavoportal Hemitransposition in Liver Transplantation: Toward a More Safe and Efficient Technique
  31. Preduodenal Portal Vein Reconstruction at Liver Transplantation: The Challenges and a Solution
  32. A paradigm shift in the intention‐to‐transplant children with biliary atresia: Outcomes of 101 cases and a review of the literature
  33. New Nutritional and Therapeutical Strategies of NEC
  34. Unusual venous collateral pathways allow for reperfusion of the intrahepatic portal venous system in children with portal vein thrombosis after split liver transplantation: Clinical relevance and management implications
  35. A national mandatory‐split liver policy: A report from the Italian experience
  36. Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report
  37. Multimodality imaging of the Meso-Rex bypass
  38. A case of Incontinentia Pigmenti associated with congenital absence of portal vein system and nodular regenerative hyperplasia
  39. CIRSE 2018
  40. Aggressive prevention and preemptive management of vascular complications after pediatric liver transplantation: A major impact on graft survival and long-term outcome
  41. Hepatic vein stenting in a 7 week/old infant with Budd–Chiari syndrome using an anterograde approach from the inferior accessory hepatic vein
  42. Caval replacement strategy in pediatric retroperitoneal tumors encasing the vena cava: a single-center experience and review of literature
  43. CPAP by helmet for treatment of acute respiratory failure after pediatric liver transplantation
  44. More is less: Calling for joining forces for rare pediatric liver tumors research
  45. Pediatric Chronic Intestinal Failure in Italy: Report from the 2016 Survey on Behalf of Italian Society for Gastroenterology, Hepatology and Nutrition (SIGENP)
  46. Hepatoblastoma in children aged less than six months at diagnosis: A report from the SIOPEL group
  47. Early and Late Factors Impacting Patient and Graft Outcome in Pediatric Liver Transplantation
  48. CIRSE 2017
  49. Beyond the Milan criteria for liver transplantation in children with hepatic tumours
  50. Bevacizumab Combined with Chemotherapy in Children Affected by Hepatocellular Carcinoma: a Single-center Experience
  51. Total internal biliary diversion during liver transplantation for type 1 progressive familial intrahepatic cholestasis: a novel approach
  52. Congenital bile duct cyst (BDC) is a more indolent disease in children compared to adults, except for Todani type IV-A BDC: results of the European multicenter study of the French Surgical Association
  53. Liver transplant in ethylmalonic encephalopathy: a new treatment for an otherwise fatal disease
  54. Genetics and Molecular Modeling of New Mutations of Familial Intrahepatic Cholestasis in a Single Italian Center
  55. Reducing left liver lobe grafts, more or less? Don't throw out the baby with the bath water…
  56. Primary prophylaxis of variceal bleeding in children and the role of MesoRex Bypass: Summary of the Baveno VI Pediatric Satellite Symposium
  57. Neonatal massive small bowel resection: How much the multidisciplinary approach does impact on the outcome?
  58. Congenital double intrahepatic portosystemic shunt: Imaging findings and endovascular closure
  59. Splitting livers: Trans-hilar or trans-umbilical division? Technical aspects and comparative outcomes
  60. Optimization and planning of operating theatre activities: an original definition of pathways and process modeling
  61. Roux-en-Y hepatico-jejunostomy for a left segmental graft: Do not twist the loop, stick it!
  62. Pancreatitis and Portal Vein Thrombosis in Children: The Chicken or the Egg Causality Dilemma
  63. P1238 : Intermediate familial intrahepatic cholestasis (IFIC): Phenotypic spectrum within the BRIC-PFIC spectrum
  64. Unusual Tract & Complication of a Percutaneous Gastrostomy Tube (PEG) in a Patient with End-Stage Liver Disease
  65. Congenital Meso-Rex Bypass
  66. Meso-Rex bypass to manage prehepatic portal hypertension after the failure of an intrahepatic portosystemic stent shunting
  67. Liver transplantation in metabolic diseases: Clinical data in Rome
  68. Intestinal failure associated liver disease in a short bowel syndrome pediatric cohort: Incidence and prognosis
  69. Living donor liver transplant (LDLT): The patient perspective
  70. Central venous catheter infections in home parenteral nutrition: Changes in two last decades in a pediatric cohort of short bowel syndrome
  71. Intrahepatic portal venous systems in children with noncirrhotic prehepatic portal hypertension: Anatomy and clinical relevance
  72. Hepatic venous reconstruction as the stake of the liver: Technical note and thoughts
  73. Preemptive Meso-Rex Bypass for Children With Idiopathic Prehepatic Portal Hypertension
  74. Long-Term Outcome of Home Parenteral Nutrition in Patients With Ultra-Short Bowel Syndrome
  75. Pancreaticoduodenectomy for malignancies in children
  76. YouTube and Pediatric Surgery. What Is the Danger for Parents?
  77. Prehepatic portal hypertension with aneurysm of the portal vein: Unusual but treatable malformative pattern
  78. Hepatoblastoma state of the art
  79. Meso-Rex Bypass—A Procedure to Cure Prehepatic Portal Hypertension: The Insight and the Inside
  80. Focal congenital hyperinsulinism managed by medical treatment: a diagnostic algorithm based on molecular genetic screening
  81. Non-alcoholic fatty liver disease and hepatocellular carcinoma in a 7-year-old obese boy: coincidence or comorbidity?
  82. Transplantation for liver tumors in children: Time to (re)set the guidelines?
  83. Giant Varicocele Inducing Chronic Pelvic Pain in a Girl
  84. Pediatric post-transplant metabolic syndrome: New clouds on the horizon
  85. ERCP with intracholedocal biopsy for the diagnosis of biliary tract rhabdomyosarcoma in children
  86. Surgically assisted trans-hepatic anterior approach for central venous catheter placement: Safety and efficacy
  87. Meso-Rex bypass as an alternative technique for portal vein reconstruction at or after liver transplantation in children: Review and perspectives
  88. Surgical management of portal hypertension in children
  89. Immediate use of an arteriovenous prosthetic graft for life-saving dialysis in a child
  90. Portal hypertension in children
  91. Congenital intrahepatic portohepatic shunt managed by interventional radiologic occlusion: a case report and literature review
  92. Too late to say it is too early - How to get children with non-cirrhotic metabolic diseases transplanted at the right time?
  93. Liver transplantation for refractory severe pruritus related to widespread multifocal hepatic focal nodular hyperplasia (FNH) in a child: Case report and review of literature
  94. Staged abdominal closure after small bowel or multivisceral transplantation
  95. Successful Tenofovir Treatment for Fulminant Hepatitis B Infection in an Infant
  96. CO6 LIVER TRANSPLANTATION IN CHILDREN: PRELIMINARY DATA IN ROME, OSPEDALE BAMBINO GESÙ
  97. Metabolic syndrome and nonalcoholic steatohepatitis recurrence after liver transplantation in children
  98. Unresectable multifocal omental and peritoneal inflammatory myofibroblastic tumor in a child: revisiting the role of adjuvant therapy
  99. With great power comes great responsibility - What pediatricians referring babies and small children to radiological interventions should know
  100. The new Guillemins station - a railway station for high-speed trains
  101. Congenital Hyperinsulinism and Glucose Hypersensitivity in Homozygous and Heterozygous Carriers of Kir6.2 (KCNJ11) Mutation V290M Mutation: KATP Channel Inactivation Mechanism and Clinical Management
  102. Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease
  103. Preemptive liver transplantation in a child with familial hypercholesterolemia
  104. P259 - Fermeture pariétale différée après transplantation intestinale ou multiviscérale
  105. Steatosis and fibrosis in paediatric liver transplant: Insidious graft’s enemies - A call for clinical studies and research
  106. Mesoportal bypass for extrahepatic portal vein obstruction in children: close to a cure for most!
  107. Psychosocial Condition After Liver Transplantation in Children: Review of the Literature From 2006 to 2008
  108. Innovative surgical techniques address the organ donation crisis, … donʼt they?
  109. Multiorgan developmental anomalies presenting as a variation of the serpentine-like syndrome: cervical fusion and brachioesophagus with intrathoracic stomach and malposition of duodenopancreas and spleen
  110. Expanding Postmortem Donor Pool Using Steatotic Liver Grafts: A New Look
  111. Isolated Liver Transplant in Infants With Short Bowel Syndrome: Insights Into Outcomes and Prognostic Factors
  112. Primary Hepatic Tumors
  113. DESCRIPTION AND MICROSCALE ANALYSIS OF SOME ENIGMATIC PALYNOMORPHS FROM THE MIDDLE DEVONIAN (GIVETIAN) OF LIBYA
  114. A new strategy for analysis of erection stages including an efficient method for creep analysis
  115. Congenital Intrahepatic Bile Duct Dilatation is a Potentially Curable Disease
  116. Immunological monitoring after organ transplantation: Potential role of soluble CD30 Blood level measurement
  117. Liver Transplantation Using Non-Heart-Beating Donors: Belgian Experience
  118. Early occurrence of hepatocellular carcinoma in biliary atresia treated by liver transplantation
  119. Living-Related Versus Deceased Donor Pediatric Liver Transplantation: A Multivariate Analysis of Technical and Immunological Complications in 235 Recipients
  120. Successful treatment of refractory ascites in a child with transjugular intrahepatic portosystemic shunt
  121. Autorenverzeichnis
  122. Die kongenitale zystische Dilatation der Gallengänge
  123. Early immunological monitoring after pediatric liver transplantation: Cytokine immune deviation and graft acceptance in 40 recipients
  124. 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group
  125. Surgical guidelines for the management of extra-hepatic portal vein obstruction
  126. Expert pediatric opinion on the Report of the Baveno IV Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension
  127. Pyloric obstruction, duodenal dilatation, and extrahepatic cholestasis: a neonatal triad suggesting multiple intestinal atresias
  128. Conservative management of pneumatosis intestinalis following haematopietic stem cell transplantation for major β thalassemia
  129. Safety of living-related liver transplantation for progressive familial intrahepatic cholestasis
  130. Foreword
  131. Isolated Liver Transplantation in an Infant With Ultrashort Gut
  132. Pediatric liver transplantation using left hepatic segments from living related donors: Surgical experience in 100 recipients at Saint-Luc University Clinics
  133. Management of End-stage Central Venous Access in Children Referred for Possible Small Bowel Transplantation
  134. Improved outcome of referrals for intestinal transplantation in the UK
  135. Recurrent Mesenchymal Hamartoma Associated with 19q Translocation. A Call for More Radical Surgical Resection
  136. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome
  137. Liver allograft radiotherapy to treat rejection in children: efficacy in orthotopic liver transplantation and long-term safety
  138. The contribution of transplantation to the treatment of liver tumors in children
  139. Liver transplantation for hepatoblastoma: Indications and contraindications in the modern era
  140. Cryopreserved Liver Cell Transplantation Controls Ornithine Transcarbamylase Deficient Patient While Awaiting Liver Transplantation
  141. Right-sided diaphragmatic hernia in infants after liver transplantation
  142. PELD Score and Posttransplant Outcome in Pediatric Liver Transplantation: A Retrospective Study of 100 Recipients
  143. CHIMERIC ENGRAFTMENT AND TISSUE ENZYME ACTIVITY AFTER LIVER CELL TRANSPLANTATION FOR ARGININOSUCCINATE-LYASE DEFICIENCY
  144. Split-Liver Transplantation for the Pediatric and Adult Recipient
  145. The role of Notch receptor expression in bile duct development and disease
  146. PELD SCORES IN PEDIATRIC LIVER TRANSPLANTATION: A RETROSPECTIVE STUDY IN 100 CHILDREN.
  147. P0193 SAFETY OF INTRAFAMILIAL LIVING-RELATED LIVER TRANSPLANTATION FOR PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS
  148. P0227 REPEATED LIVER CELL TRANSPLANTATION VIA PORTH A CATH SYSTEM IN A CHILD
  149. P0772 SMALL BOWEL TRANSPLANT (SBTX) IN CHILDREN: A DECADE OF EXPERIENCE FROM A SINGLE CENTRE
  150. P0250* SAFETY AND EFFICACY OF SIROLIMUS IN CHILDREN FOLLOWING CHRONIC REJECTION AND/OR NEPHROTOXICITY POST INTESTINAL TRANSPLANT (ITX) AND LIVER TRANSPLANTATION (LTX).
  151. Seamless management of biliary atresia in England and Wales (1999–2002)
  152. Management of hepatic epithelioid haemangio-endothelioma in children: what option?
  153. Permanent access to the portal system for cellular transplantation using an implantable port device
  154. Bile duct of luschka leading to bile leak after cholecystectomy—revisiting the biliary anatomy
  155. Familial Hepatoblastoma and APC gene mutations: renewed call for molecular research
  156. Meso-portal bypass in children with portal vein thrombosis: rapid increase of the intrahepatic portal venous flow after direct portal hepatic reperfusion
  157. Renal function following liver transplantation for unresectable hepatoblastoma
  158. Risk factors for death and graft loss after small bowel transplantation
  159. Worth Continuing Doing Ex Situ Liver Graft Splitting? A Single-Center Analysis
  160. Partial splenectomy in cystic fibrosis patients with hypersplenism
  161. Congenital, solitary, large, intrahepatic arterioportal fistula in a child: management and review of the literature
  162. New perspective for the management of near-total or total intestinal aganglionosis in infants
  163. Congenital malignant peritoneal mesothelioma
  164. Progenitor cells of the biliary epithelial cell lineage
  165. Ex Situ Preparation of Left Split-Liver Grafts With Left Vascular Pedicle Only: Is it Safe?
  166. Hepatic vein reconstruction in ex situ split-liver transplantation
  167. Benefits of early diagnosis and preemptive treatment of biliary tract complications after major blunt liver trauma in children
  168. Difficult Management Choices For Infants With Short Bowel Syndrome and Liver Failure
  169. Induction therapy for small bowel transplant recipients: early experience in Birmingham, UK
  170. Neonatal Liver Transplantation for Fulminant Hepatitis Caused by Herpes Simplex Virus Type 2
  171. Transhepatic Hickman Line Placement: Improving Line Stability by Surgically Assisted Radiologic Placement
  172. Improved technique of portal vein reconstruction in pediatric liver transplant recipients with portal vein hypoplasia
  173. Inferior Vena Cava Occlusion and Protein-losing Enteropathy After Liver Transplantation in Children
  174. Strategy for hepatoblastoma management: Transplant versus nontransplant surgery
  175. Techniques for and outcome of liver transplantation in neonates and infants weighing up to 5 kilograms
  176. VENTILATORY FAILURE AFTER PEDIATRIC LIVER TRANSPLANTATION
  177. Technique for ex situ cadaveric liver graft division
  178. Successful treatment of refractory ascites in a child with transjugular intrahepatic portosystemic shunt
  179. THE USE OF LIVER GRAFTS FROM DONORS WITH BACTERIAL MENINGITIS
  180. Liver transplantation in children
  181. Early experience of paediatric intestinal transplantation in the United Kingdom, 1993 to 1999
  182. Treatment of Microvillus Inclusion Disease by Intestinal Transplantation
  183. ABSENCE OF THE LEFT PORTAL VEIN: A DIFFICULTY FOR REDUCTION OF LIVER GRAFTS?
  184. Size Reduction of Small Bowels from Adult Cadaveric Donors to Alleviate the Scarcity of Pediatric Size-Matched Organs: An Anatomical and Feasibility Study. Transplantation 2000; 69: 1392.
  185. EN BLOC COMBINED REDUCED-LIVER AND SMALL BOWEL TRANSPLANTS
  186. Pseudo-obstruction in children: transplant or wait?
  187. Treatment of Extrahepatic Portal Hypertension in Children by Mesenteric-to-left Portal Vein Bypass: a New Physiological Procedure
  188. PRESERVED VASCULAR HOMOGRAFT FOR REVASCULARIZATION OF PEDIATRIC LIVER TRANSPLANT1
  189. TECHNICAL-VARIANT LIVER GRAFTS IN PEDIATRIC LIVER TRANSPLANTATION: BACK TO THE FUTURE
  190. TREATMENT OF MICROVILLUS INCLUSION DISEASE BY INTESTINAL TRANSPLANTATION : RETENTION OF THE NATIVE ILEOCAECAL VALVE AND COLON IMPROVES OUTCOME
  191. Cricopharyngeal Achalasia: Case Reports and Review of the Literature
  192. Pediatric liver transplantation with cadaveric or living related donors: Comparative results in 90 elective recipients of primary grafts
  193. Intraabdominal pyloromyotomy through the umbilical route: A technical improvement
  194. Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients
  195. Conversion from tacrolimus to microemulsion formulation of cyclosporine in pediatric liver transplantation
  196. Gastric Cystic Duplication Communicating with a Bifid Pancreas: A Rare Cause of Recurrent Pancreatitis
  197. Pediatric liver transplantation: from the full-size liver graft to reduced, split, and living related liver transplantation
  198. Use of granulocyte macrophage colony stimulating factor in children after orthotopic liver transplantation
  199. REJECTION INCIDENCES AFTER PEDIATRIC LIVER TRANSPLANTATION WITH CADAVERIC OR LIVING-RELATED DONORS: AN IMMUNOLOGICAL PARADOX?
  200. ETHICAL ISSUES IN LIVING RELATED (LR) OR CADAVERIC (Cad) PEDIATRIC LIVER TRANSPLANTATION (OLT)
  201. PEDIATRIC LIVER TRANSPLANTATION : FROM THE FULL-SIZE LIVER GRAFT(FS) TO THE REDUCED (RED), SPLIT AND LIVING RELATED LIVER TRANSPLANTATION(LRLT)
  202. FIVE YEARS POST TRANSPLANT STATUS IN 96 CHILDREN WHO RECEIVED OLT BETWEEN 1984 AND 1990
  203. REJECTION INCIDENCES AFTER PEDIATRIC LIVER TRANSPLANTATION WITH CADAVERIC OR LIVING-RELATED DONORS: AN IMMUNOLOGICAL PARADOX?
  204. ETHICAL ISSUES IN LIVING RELATED (LR) OR CADAVERIC (Cad) PEDIATRIC LIVER TRANSPLANTATION (OLT).
  205. PEDIATRIC LIVER TRANSPLANTATION : FROM THE FULL-SIZE LIVER GRAFT(FS) TO THE REDUCED (RED), SPLIT AND LIVING RELATED LIVER TRANSPLANTATION(LRLT).
  206. FIVE YEARS POST TRANSPLANT STATUS IN 96 CHILDREN WHO RECEIVED OLT BETWEEN 1984 AND 1990.
  207. FIVE YEARS POST TRANSPLANT STATUS IN 96 CHILDREN WHO RECEIVED OLT BETWEEN 1984 AND 1990
  208. PRELIMINARY ANALYSIS OF LONGITUDINAL GROWTH MEASUREMENTS AMONG 384 CHIDREN WHO RECEIVED OLT BETWEEN 1984 AND 1995.
  209. Direct bypassing of extrahepatic portal venous obstruction in children: A new technique for combined hepatic portal revascularization and treatment of extrahepatic portal hypertension
  210. Delayed primary closure of the abdominal wall after cadaveric and living related donor liver graft transplantation in children: a safe and useful technique
  211. EARLY HEPATOCYTE, ENDOTHELIAL, AND BILE DUCT CELL INJURY AFTER PEDIATRIC LIVER TRANSPLANTATION FROM CADAVERIC OR LIVING-RELATED DONORS
  212. Delayed primary closure of the abdominal wall after cadaveric and living related donor liver graft transplantation in children: a safe and useful technique
  213. Granulocyte macrophage colony stimulating factor (GM-CSF) chez les receveurs de transplants hépatiques
  214. FK506 et syndromes lymphoprolifératifs chez les enfants transplantés hépatiques
  215. Arteriomesenteric syndrome as a cause of duodenal obstruction in children with cerebral palsy
  216. Clinical pharmacokinetics of Neoral in pediatric recipients of primary liver transplants
  217. Early Signs And Risk Factors For The Increased Incidence Of Epstein-Barr Virus-Related Posttransplant Lymphoproliferative Diseases In Pediatric Liver Transplant Recipients Treated With Tacrolimus
  218. Hirschsprung's disease: A 20-year experience
  219. Cavocaval liver transplantation without venovenous bypass and without temporary portocaval shunting: the ideal technique for adult liver grafting?
  220. RISK FACTORS FOR THE INCREASED INCIDENCE OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS TREATED WITH TACROLIMUS
  221. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC STENT SHUNT (TIPSS) IN CHILDREN.
  222. Adult liver transplantation and abnormalities of splanchnic veins: experience in 53 patients
  223. Adult liver transplantation and abnormalities of splanchnic veins: experience in 53 patients
  224. ORIGINAL EXTRAHILAR APPROACH FOR HEPATIC PORTAL REVASCULARIZATION AND RELIEF OF EXTRAHEPATIC PORTAL HYPERTENSION RELATED TO LATE PORTAL VEIN THROMBOSIS AFTER PEDIATRIC LIVER TRANSPLANTATION
  225. PROPHYLACTIC IMMUNOSUPPRESSION WITH ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL ANTIBODY LO-TACT-1 VERSUS OKT3 IN LIVER ALLOGRAFTING
  226. GLUCURONIDATION OF DIFLUNISAL, (−)-MORPHINE, 4-NITROPHENOL, AND PROPOFOL IN LIVER MICROSOMES OF TWO PATIENTS WITH CRIGLER–NAJJAR SYNDROME TYPE I
  227. 121 RELIEF OF EXTRAHEPATIC PORTAL HYPERTENSION DUE TO PORTAL VEIN THROMBOSIS IN CHILDREN: ORIGINAL EXTRAHILAR APPROACH.
  228. 34 LIVING RELATED LIVER TRANSPLANTATION: THE FIRST 2 1/2 YEAR EXPERIENCE IN BRUSSELS.
  229. Extrahepatic glucuronidation of propofol in man: possible contribution of gut wall and kidney
  230. Laparoscopic splenectomy in adults and children: Experience with 31 patients
  231. MICROEMULSION FORMULATION OF CYCLOSPORINE IN PEDIATRIC LIVER TRANSPLANTATION
  232. Primary calcification in post-transplantation lymphoproliferative disorder involving the hepatic graft: an exceptional finding
  233. Devenir au long cours des enfants transplantés hépatiques
  234. ORTHOTOPIC LIVER TRANSPLANTATION FOR CRIGLER-NAJJAR TYPE I DISEASE IN SIX CHILDREN
  235. Mitochondrial respiratory chain defect: a new etiology for neonatalcholestasis and early liver insufficiency
  236. Standardized quick en bloc technique for procurement of cadaveric liver grafts for pediatric liver transplantation
  237. SPLIT LIVER TRANSPLANTATION IN EUROPE—1988 to 1993
  238. Primary management of biliary atresia: Don't change the rules
  239. Role of hepatitis C virus in chronic liver disease occurring after orthotopic liver transplantation.
  240. 21 RESCUE FK 506 THERAPY FOR RESISTANT REJECTION AFTER PEDIATRIC LIVER TRANSPLANTATION (OLT)
  241. A new method for rat accessory hepatic transplantation-the cervical approach
  242. A new method for rat accessory hepatic transplantation ? the cervical approach
  243. Percutaneous transjugular intrahepatic stent shunt for treatment of intractable varicose bleeding in paediatric patients
  244. Hepatobiliary scintigraphy in a patient with bilhemia
  245. Sequential treatment of biliary atresia with kasai portoenterostomy and liver transplantation: A review
  246. Technical problems in shipped hepatic allografts: the UCL experience
  247. Technical problems in shipped hepatic allografts: the UCL experience
  248. Sequential treatment of biliary atresia with Kasai portoenterostomy and liver transplantation: A review*1
  249. LIVER PROCUREMENT WITHOUT IN SITU PORTAL PERFUSION
  250. CONVERSION FROM CYCLOSPORINE TO FK506 FOR SALVAGE OF IMMUNOCOMPROMISED PEDIATRIC LIVER ALLOGRAFTS EFFICACY, TOXICITY, AND DOSE REGIMEN IN 23 CHILDREN
  251. Impact Of Innovative Techniques On The Waiting List And Results In Pediatric Liver Transplantation
  252. THE UNRELIABILITY OF THE LIDOCAINE/MONOETHYLGLYCINEXYLIDIDE TEST FOR ASSESSMENT OF LIVER DONORS
  253. Management of intra-abdominal organ injury following blunt abdominal trauma in children
  254. MONOCLONAL ANTIBODIES IN PROPHYLACTIC IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION A RANDOMIZED CONTROLLED TRIAL COMPARING OKT3 AND ANTI-IL-2 RECEPTOR MONOCLONAL ANTIBODY LO-TACT-1
  255. Progressive cardiac failure following orthotopic liver transplantation for type IV glycogenosis
  256. Acute adenovirus hepatitis in liver transplant recipients
  257. Platelet aggregates in small lung vessels and death during liver transplantation
  258. Liver transplantation in children with biliary atresia and polysplenia syndrome
  259. 53 LIVER TRANSPLANTATION FOR METABOLIC DISORDERS IN CHILDREN
  260. Unifocal Stricture of the Common Bile Duct in Two Children
  261. Liver transplantation in children less than 1 year of age
  262. LIVER TRANSPLANTATION BEFORE ONE YEAR
  263. Size Reduction of the Donor Liver Is a Safe Way to Alleviate the Shortage of Size-Matched Organs in Pediatric Liver Transplantation
  264. Obstruction to hepatic venous drainage after liver transplantation: treatment with balloon angioplasty.
  265. Acute and fulminant adenovirus hepatitis in liver transplant recipients: Diagnosis and management
  266. Liver Transplantation for Biliary Atresia: Indications and Results
  267. Pediatric liver transplantation: Report on 52 patients with a 2-year survival of 86%
  268. Primary Hepatic Tumours
  269. Liver tumors and resections